Rights and permissions
About this article
Cite this article
Temozolomide more cost effective than combo therapy in glioblastoma. Pharmacoecon. Outcomes News 485, 5 (2005). https://doi.org/10.2165/00151234-200504850-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504850-00007